The effects of chemotherapy on iron, folate, and vitamin B 12  metabolism in tuberculosis.
D000179:Acrylates / Q000652:urine; D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000740:Anemia / Q000150:complications; D000747:Anemia, Hypochromic / Q000150:complications; D000748:Anemia, Macrocytic / Q000150:complications; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004920:Erythropoiesis; D005365:FIGLU Test; D005260:Female; D005492:Folic Acid / Q000097:blood / Q000378:metabolism*; D005494:Folic Acid Deficiency / Q000150:complications; D006801:Humans; D007093:Imidazoles / Q000652:urine; D007501:Iron / Q000097:blood / Q000378:metabolism*; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013307:Streptomycin / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000378:metabolism*; D014805:Vitamin B 12 / Q000097:blood / Q000378:metabolism*
D000179:Acrylates; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007093:Imidazoles; D005492:Folic Acid; D007501:Iron; D014805:Vitamin B 12; D007538:Isoniazid; D013307:Streptomycin